Cargando…
Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
Immune checkpoint inhibitors (ICIs) have been applied to clinical practice and achieved significant therapeutic benefit in a variety of human malignancies. These drugs not only enhance the body’s antitumor immune response but also produce side effects called immune-related adverse events (irAEs). Al...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518129/ https://www.ncbi.nlm.nih.gov/pubmed/33042827 http://dx.doi.org/10.3389/fonc.2020.01785 |